StockData
Valneva SE logo

Valneva SE (VALN) stock

VALNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 17, 2026Score 1/30
$5.37+0.03 (+0.47%)

Close on Nov 19, 2026Market cap $465.52MP/E –Yield –

Valneva shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

For fiscal 2025 it was 168M, up 15.4% from the year before. The highest annual figure on record is 168M in fiscal 2025.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 2025168M+15.4%
FY2024Dec 31, 2024146M+5.1%
FY2023Dec 31, 2023139M+20.0%
FY2022Dec 31, 2022115M+18.3%
FY2021Dec 31, 202198M+7.6%
FY2020Dec 31, 202091M-1.1%
FY2019Dec 31, 201992M–

More Valneva figures

See a number that looks wrong?